Yahoo Web Search

Search results

  1. 3 days ago · According to 11 analysts, the average rating for CRL stock is "Buy." The 12-month stock price forecast is $259.8, which is an increase of 19.61% from the latest price.

    • Full Company Profile

      Ticker Symbol: CRL: Exchange: NYSE: Fiscal Year: January -...

    • Revenue (Ttm)

      CRL Revenue Charles River Laboratories International had...

    • Dividends

      CRL News. 9 days ago - Charles River Laboratories Announces...

    • Forecast

      The 10 analysts with 12-month price forecasts for CRL stock...

    • Statistics

      Stock Price Statistics The stock price has increased by...

    • Chart

      Interactive stock price chart for Charles River Laboratories...

    • Market Cap

      Since June 23, 2000, CRL's market cap has increased from...

    • CRL Number of Employees 2000-2022

      Stock Analysis Pro. Watchlist. Collapse. Charles River...

  2. May 13, 2024 · Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term. Zacks Equity Research. Mon, May 13, 2024, 9:40 AM 2 min read. In this article: CRL. For new and old investors,...

  3. 1 day ago · Charles River Laboratories International Inc. CRL. Latest Trade. 217.21 USD. -0.34. -0.16% As of May 26, 2024. Values delayed up to 15 minutes. Today's Range. 215.68 - 217.89. 52 Week Range....

    • 222-6000
  4. 1 day ago · 11 analysts have issued twelve-month price objectives for Charles River Laboratories International's stock. Their CRL share price targets range from $205.00 to $290.00. On average, they anticipate the company's share price to reach $255.27 in the next year. This suggests a possible upside of 17.5% from the stock's current price.

    • (781) 222-6000
    • 251 BALLARDVALE STREET, WILMINGTON MA, 01887
    • askcharlesriver@crl.com
  5. May 13, 2024 · Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term | Nasdaq. Stocks. Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term. May 13,...

  6. May 17, 2024 · Analysis. Ratings: Select Ratings. Date Range: Select Date. Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold' Lighting Rock Research Fri, Feb. 16 1 Comment....

  7. May 20, 2024 · 20 May, 2024. Data. Company Financials +. 14 Analysts. CRL Stock Overview. Charles River Laboratories International, Inc. About the company. Rewards. Trading at 23.6% below our estimate of its fair value. Earnings are forecast to grow 13.56% per year. Risk Analysis. Has a high level of debt. Significant insider selling over the past 3 months.

  1. People also search for